DRUG POLICY ALLIANCE for DRUG POLICY ALLIANCE
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 17, 2022 | $87,644 | Replaced |
| 3rd Quarter - Amendment | Oct 17, 2022 | $87,644 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Lobbied for $150 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARITZA PEREZ MEDINA | — |
| GRANT SMITH | — |
Law Enforcement/Crime/Criminal Justice LAW
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL LISZEWSKI New | — |
| MARITZA PEREZ MEDINA New | — |
Budget/Appropriations BUD
Lobbied for $150 million in appropriations for syringe service programs and other harm reduction tools/services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARITZA PEREZ MEDINA New | — |
| GRANT SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.